Activation of CYP1A1 gene expression during primary culture of mouse hepatocytes. 2005

Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
Department of Toxicology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Sugitani 2630, Toyama 930-0194, Japan.

Expression of CYP1A1 mRNA in mouse hepatocytes in primary culture was investigated. The expression was obvious on day 3 of culture without addition of any known ligands of the aryl hydrocarbon receptor and increased with culture period. Removal of insulin from and addition of hydrogen peroxide to the medium enhanced and suppressed the expression, respectively. The CYP1A1 mRNA expression was also enhanced in the presence of anti-oxidant, t-butylhydroquinone, in the medium. Several kinds of kinase inhibitors markedly increased the CYP1A1 mRNA expression. In contrast, the inhibitory expression was prolonged in the presence of okadaic acid, a potent inhibitor of serine/threonine phosphatase PP1 and PP2. These observations suggest that there might be a repressive pathway in the regulation of CYP1A1 mRNA expression and that the presently observed expression pathway differs at several points from those previously reported, such as ligand-activated aryl hydrocarbon receptor- or omeprazole-mediated expression. Modulation of CYP1A2 mRNA expression after exposing hepatocytes to agents affecting phosphorylation pathways differed from that of CYP1A1 mRNA. This implies that regulatory pathways for CYP1A1 and CYP1A2 expression may differ.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D007701 Kinetin A furanyl adenine found in PLANTS and FUNGI. It has plant growth regulation effects. 6-Furfuryladenine,6-Furfurylaminopurine,6 Furfuryladenine,6 Furfurylaminopurine
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D006873 Hydroquinones Derivatives of hydroquinone (1,4-dihydrobenzene) made by reduction of BENZOQUINONES. Quinol,p-Dihydroxybenzenes,para-Dihydroxybenzenes,Quinols,p Dihydroxybenzenes,para Dihydroxybenzenes

Related Publications

Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
March 1993, Japanese journal of cancer research : Gann,
Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
July 1996, The Journal of biological chemistry,
Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
August 1996, Biochimica et biophysica acta,
Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
July 1992, Biochemical pharmacology,
Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
September 1983, Molecular and cellular biology,
Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
May 1988, General and comparative endocrinology,
Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
January 1995, Archives of biochemistry and biophysics,
Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
January 1994, Archives of biochemistry and biophysics,
Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
October 1995, Hepatology (Baltimore, Md.),
Hisako Tamaki, and Tsutomu Sakuma, and Yo-Ichi Uchida, and Atika Jaruchotikamol, and Nobuo Nemoto
December 2011, Toxicology in vitro : an international journal published in association with BIBRA,
Copied contents to your clipboard!